Engrail Therapeutics - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

WSP Global raises Arcadis takeover offer to €51.50 as engineering consolidation accelerates

Wall Street welcomes Repligen’s $1.5bn BioLife deal, but integration now matters

Read More

Pharma Industry News

Engrail Therapeutics initiates ENX-102 Phase 2 trial in generalized anxiety disorder

Engrail Therapeutics, a neuroscience company committed to advancing transformational therapies, announced the start of a multi-center Phase 2…

byPallavi Madhiraju

July 19, 2023

web analytics